Contact Us

Report from Biovica’s Extra Shareholder’s Meeting on March 20, 2019

2019-03-20 17:00

Uppsala, Sweden, March 20, 2019. Lars Holmqvist was elected Chairman of the Board and a warrant program of 175,000 options to the Board was approved.

Below is a summary of the decisions taken at the Extra Shareholder’s Meeting.

The Meeting resolved that the Chairman of the Board should be compensated with SEK 200,000 until the next Annual General Meeting.

Lars Holmqvist was elected Chairman of the Board until the end of the next Annual General Meeting.

The meeting resolved in accordance with the proposed warrant program of 175,000 options to the Board.

More information:

Anders Rylander, CEO Biovica.
Phone: +46 (0)18 444 48 35,
E-mail: anders.rylander@biovica.com

>4,500

Numbers of patients in studies

28

Publications

19

Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program

No